Impact of SARS‐CoV‐2 pandemic on pulmonary hypertension out‐patient clinics in Germany: a multi‐centre study
Athiththan Yogeswaran, Henning Gall, Khodr Tello, Ekkehard Grünig, Panagiota Xanthouli, Ralf Ewert, Jan C. Kamp, Karen M. Olsson, Max Wißmüller, Stephan Rosenkranz, Hans Klose, Lars Harbaum, Tobias Lange, Christian Opitz, Andrea Waelde, Katrin Milger, Natascha Sommer, Werner Seeger, Hossein Ardeschir Ghofrani, Manuel J. Richter
Abstract
Pulmonary hypertension is frequently underdiagnosed, and referral is delayed with subsequent impact on outcomes. During the SARS-CoV-2 pandemic, restrictions on daily life and changes in hospitals' daily routine care were introduced in Germany. This multi-centre study provides evidence for a negative influence of these restrictions on patient care in pulmonary hypertension expert referral centres.
Topics & Concepts
MedicinePandemicSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakPulmonary hypertensionVirologyIntensive care medicineEmergency medicineInternal medicineDiseaseOutbreakInfectious disease (medical specialty)Pulmonary Hypertension Research and TreatmentsUltrasound in Clinical ApplicationsLiver Disease and Transplantation